Updated:
Tang Capital Management
Kevin Tang founded Tang Capital Management, a firm that invests primarily in healthcare and biotechnology.
Tang Capital Management
Kevin Tang founded Tang Capital Management, a firm that invests primarily in healthcare and biotechnology. Tang previously worked at a healthcare-focused hedge fund before launching his own vehicle; the firm is structured as a single family office managing his personal wealth. Tang Capital targets public and private biotechnology companies, deploying capital across clinical-stage drug developers, platform technology firms, and life sciences tools. The firm is known for activist-style positions in public biotech companies, occasionally pushing for strategic changes such as mergers or pipeline refocusing. Deals include investments in firms like Ra Pharmaceuticals (acquired by UCB) and Portola Pharmaceuticals (acquired by Alexion). Geographically, Tang Capital focuses on US-based companies, particularly on the West Coast and in the Northeast biotech hubs. The firm has offices in San Diego (headquarters), Palo Alto, New York, and Boston, reflecting the geographic concentration of its portfolio. Kevin Tang is the sole named principal; the broader team size is not publicly disclosed. In 2024, Tang Capital participated in a financing round for an undisclosed private biotech startup (per public filings, 2024). Tang Capital distinguishes itself through a concentrated portfolio and activist approach, unusual for a single family office in the biotech space. The firm takes board seats in portfolio companies and publicly engages with management, resembling a hedge fund in execution while operating with the permanence of family capital.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Additional offices
Palo Alto, CA · New York, NY · Boston, MA
Principals
Kevin Tang
Founder and Portfolio Manager
Sector focus
Frequently asked questions
Who founded and runs Tang Capital Management?
Kevin Tang is the founder and portfolio manager. He previously worked at a healthcare-focused hedge fund before establishing the firm as a single family office for his own capital (per public record).
What types of investments does Tang Capital Management make?
The firm focuses on biotechnology and life sciences, investing in both public and private companies. It takes concentrated, often activist positions in public biotech firms and also participates in private financings (per public filings).
Is Tang Capital Management structured as a family office or a traditional asset manager?
Tang Capital operates as a single family office, managing Kevin Tang's personal wealth. It does not manage third-party capital, distinguishing it from traditional hedge funds or venture capital firms.
What is Tang Capital's investment approach?
The firm takes a concentrated, activist approach. It often seeks board representation and engages with management to drive strategic changes like mergers, pipeline shifts, or capital allocation decisions in portfolio companies (per public record).
What are some notable investments or exits for Tang Capital?
Known positions include investments in Ra Pharmaceuticals, which was acquired by UCB, and Portola Pharmaceuticals, which was acquired by Alexion (per public filings). These reflect the firm's focus on clinical-stage biotech companies with eventual exit via acquisition.
Where are Tang Capital's offices located?
The firm's headquarters are in San Diego, California, with additional offices in Palo Alto, California; New York, New York; and Boston, Massachusetts. These locations align with major US biotechnology hubs (per public record).
Does Tang Capital manage money for other investors?
No. Tang Capital Management is a single family office managing Kevin Tang's own wealth. It does not accept external capital from institutional investors or high-net-worth individuals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: